[2] Pluralibacter gergoviae has been isolated from maize, grapes, coffee beans, spring water, fruit flies, and pink bollworms.

[4] It is an uncommon human pathogen, most commonly as an opportunistic nosocomial infection.

One hospital in Spain reported the organism to represent 0.4% of clinical Enterobacter isolates.

Risk factors include prolonged hospital stays, "immunosuppression, the presence of a foreign device, prior use of anti-microbial agents in the patient involved, and extremes of age.

[7] Pluralibacter gergoviae is resistant to penicillins (specifically benzylpenicillin, oxacillin), macrolides (with the exception of azithromycin), lincosamides (specifically lincomycin and clindamycin), streptogramins, rifampicin, fusidic acid, and fosfomycin.